MESALAZINA ALFASIGMA 400mg gastro-resistant tablets medication leaflet

A07EC02 mesalazine • Alimentary tract and metabolism | Intestinal antiinflammatory agents | Aminosalicylic acid and similar agents

Mesalazine is a medication used to treat inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. It is effective for both inducing remission and maintaining it, helping to reduce inflammation in the intestinal lining.

Mesalazine works locally in the intestine by inhibiting the production of inflammatory substances, such as prostaglandins and leukotrienes. It is available in the form of tablets, suppositories, or enemas, depending on the location of the inflammation in the digestive tract.

Side effects are usually mild and may include nausea, abdominal pain, diarrhea, headache, or skin rashes. In rare cases, more serious reactions can occur, such as kidney or liver dysfunction or severe allergic reactions. It is important to take mesalazine as prescribed by a doctor, with regular blood and urine tests to monitor for potential complications.

General data about MESALAZINA ALFASIGMA 400mg

Substance: mesalazine

Date of last drug list: 01-08-2023

Commercial code: W69663002

Concentration: 400mg

Pharmaceutical form: gastro-resistant tablets

Quantity: 120

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: SOFAR S.P.A. - ITALIA

Holder: ALFASIGMA S.p.A. - ITALIA

Number: 12452/2019/02

Shelf life: 3 years

Concentrations available for mesalazine

1000mg, 1200mg, 1g, 1g/dose, 250mg, 2g, 400mg, 4g/60ml, 500mg, 800mg

Other substances similar to mesalazine